Last $66.55 USD
Change Today +0.76 / 1.16%
Volume 80.8K
NHI On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

natl health investors inc (NHI) Snapshot

Open
$65.82
Previous Close
$65.79
Day High
$66.67
Day Low
$65.82
52 Week High
11/5/14 - $67.95
52 Week Low
01/2/14 - $54.75
Market Cap
2.2B
Average Volume 10 Days
101.4K
EPS TTM
$3.05
Shares Outstanding
33.1M
EX-Date
09/26/14
P/E TM
21.8x
Dividend
$3.08
Dividend Yield
4.58%
Current Stock Chart for NATL HEALTH INVESTORS INC (NHI)

natl health investors inc (NHI) Related Bloomberg News

View More Bloomberg News

natl health investors inc (NHI) Related Businessweek News

No Related Businessweek News Found

natl health investors inc (NHI) Details

National Health Investors Inc. is a real estate investment trust. It invests in the real estate markets of United States. The firm invests in the health care properties primarily in the long-term care and senior housing industries. It specializes in financing healthcare real estate by sale-leaseback, joint-venture, mezz loans, and mortgage loans. National Health Investors Inc. was formed in 1991 and is based in Murfreesboro, Tennessee.

11 Employees
Last Reported Date: 02/18/14
Founded in 1991

natl health investors inc (NHI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $600.0K
Principal Financial Officer and Chief Account...
Total Annual Compensation: $350.4K
Chief Credit Officer
Total Annual Compensation: $226.3K
Compensation as of Fiscal Year 2013.

natl health investors inc (NHI) Key Developments

National Health Investors Inc. Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Year 2014

National Health Investors Inc. reported consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $44,478,000 against $30,849,000 a year ago. Income from continuing operations was $25,516,000 against $22,341,000 a year ago. Net income attributable to common stockholders was $25,250,000 against $42,744,000 a year ago. Basic and diluted income from continuing operations attributable to common stockholders was $0.76 against $0.79 a year ago. Net income attributable to common stockholders was $0.76 against $1.53 a year ago. Funds from operations were $34,598,000 against $28,880,000 a year ago. Normalized AFFO were $31,168,000 against $25,216,000 a year ago. Normalized FAD was $31,391,000 against $25,469,000 a year ago. Basic and diluted normalized AFFO per common share was $0.94 against $0.90 a year ago. Basic and diluted normalized FAD per common share was $0.95 against $0.91 a year ago. Normalized FFO was $34,598,000 or $1.05 per diluted share, compared with $26,819,000 or $0.96 per diluted share for the same period in 2013, an increase of 9.4%. For the nine months, the company reported revenue of $131,775,000 against $85,076,000 a year ago. Income from continuing operations was $74,952,000 against $55,046,000 a year ago. Net income attributable to common stockholders was $74,080,000 against $78,408,000 a year ago. Basic and diluted income from continuing operations attributable to common stockholders was $2.24 against $1.95 a year ago. Net income attributable to common stockholders was $2.24 against $2.81 a year ago. Funds from operations were $101,711,000 against $73,342,000 a year ago. Normalized AFFO were $93,104,000 against $72,067,000 a year ago. Normalized FAD was $94,900,000 against $74,153,000 a year ago. Basic and diluted FFO per common share was $3.07 against $2.63 a year ago. Basic and diluted normalized FAD per common share was $2.87 against $2.66 a year ago. Normalized FFO for the first 9 months was $103,856,000 or $3.14 per diluted share compared with $75,879,000 or $2.72 per diluted share for the same period in 2013, an increase of 15.4%. For the year 2014, the company expects net income per diluted share attributable to common stockholders of $3.00 against $3.02. Normalized FFO per diluted common share is expected to be $4.18 against $4.20. Normalized AFFO per diluted common share is expected to be $3.74 against $3.76.

National Health Investors Inc. to Report Q3, 2014 Results on Nov 03, 2014

National Health Investors Inc. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 03, 2014

National Health Investors Inc., Q3 2014 Earnings Call, Nov 04, 2014

National Health Investors Inc., Q3 2014 Earnings Call, Nov 04, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NHI:US $66.55 USD +0.76

NHI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aviv REIT Inc $33.30 USD +0.17
Healthcare Realty Trust Inc $26.35 USD +0.23
LTC Properties Inc $41.74 USD +0.39
Medical Properties Trust Inc $13.87 USD +0.15
Sabra Health Care REIT Inc $28.38 USD +0.20
View Industry Companies
 

Industry Analysis

NHI

Industry Average

Valuation NHI Industry Range
No financial data is available for NHI.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATL HEALTH INVESTORS INC, please visit www.nhireit.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.